InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
February 12, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for ...
InMed Pharmaceuticals: InMed Reports Second Quarter Fiscal 2025 Financial Results and ...
InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary ...